Literature DB >> 221583

Antibody blockade of lysis by T lymphocyte effectors generated against syngeneic SV40 transformed cells.

L R Gooding.   

Abstract

Antibody blockade of cell-mediated lysis was used to probe the cell surface structures recognized by T lymphocytes generated to syngeneic SV40 virus-transformed mouse cells. Alloantisera to H-2 antigens were highly effective in inhibiting lysis. Anti-H2 antibody blockade of lysis was haplotype specific even on transformed F1 target cells. Inhibition occurred only when antibody was bound to the target cell. Antibody binding to the effector did not inhibit lysis. Inhibition required that antibody be bound to the H-2 molecule itself; antibody to molecules associated with H-2, such as beta2-microglobulin, had no effect. Attempts to block lysis by using antisera to known virus-coded molecules were uniformly unsuccessful. These results are discussed in light of current controversy concerning the nature of the SV40 virus-specific transplantation antigen.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 221583

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Production of prostaglandin E₂ in response to infection with modified vaccinia Ankara virus.

Authors:  Justin J Pollara; April H Spesock; David J Pickup; Scott M Laster; Ian T D Petty
Journal:  Virology       Date:  2012-04-23       Impact factor: 3.616

2.  Cell-mediated immunity to herpes simplex virus: specificity of cytotoxic T cells.

Authors:  M J Lawman; R J Courtney; R Eberle; P A Schaffer; M K O'Hara; B T Rouse
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

3.  Quantitative variations in the expression of H-2 antigens on murine leukemia virus-induced tumor cells can affect the H-2 restriction patterns of tumor-specific cytolytic T lymphocytes.

Authors:  F Plata; A F Tilkin; J P Lévy; F Lilly
Journal:  J Exp Med       Date:  1981-12-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.